Assisted Reproductive Technology (ART) Market By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), By End-use (Hospitals, Fertility Clinics, Others), By Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction, Others), By Product Type (Women Younger Than Age 35, Women Older Than Age 35) and By Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa), and COVID-19 Analysis – Global Forecast 2022 to 2031

Assisted reproductive technology (ART) Market Analysis and Insights:

It is projected that the global assisted reproductive technology (ART) market will reach a value of USD 52.31 billion in 2031, having grown from 2023 to 2031 at a compound annual growth rate (CAGR) of 8.27%.

The ART sector experiences significant momentum due to various factors. The escalating infertility rates stand out as a primary catalyst for the uptake of ART techniques like in vitro fertilization (IVF) and surrogacy. Factors such as evolving lifestyles, delayed childbearing, and the heightened occurrence of fertility-affecting conditions all play a role in propelling the demand for ART services. Moreover, technological and medical advancements have notably enhanced the success rates of ART procedures, rendering them a feasible choice for couples grappling with natural conception challenges. Increasing public understanding and acceptance of ART, coupled with diminishing stigma and societal taboos related to infertility, collectively bolster market growth.

Additionally, the availability of supportive reimbursement schemes and insurance coverage for ART treatments in select regions facilitates accessibility and affordability, further buoying the market. The rising prevalence of individuals from same-sex couples and single-parent households turning to ART to realize their parenthood aspirations also contributes to market expansion. Despite such affirmative trends, obstacles like the steep treatment costs, ethical and legal complexities, as well as inadequate healthcare infrastructure in specific areas can impede the market's progress. In essence, the surging demand, advancements in technology, expanding societal acceptance, and favorable policy frameworks are key drivers fueling the growth of the ART market.

Assisted reproductive technology (ART) Market Definition

A variety of medical procedures that manipulate eggs, sperm, or embryos outside of the body to help people or couples get pregnant are referred to as assisted reproductive technology. These methods usually include processes such as intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and in vitro fertilization (IVF).

Assisted reproductive technology (ART) holds a pivotal role in contemporary healthcare, providing reproductive solutions to individuals and couples confronting infertility or related reproductive obstacles. It empowers them to realize their dream of becoming parents, thereby enhancing their mental well-being and overall satisfaction within the family unit. Intrauterine insemination (IUI) and in vitro fertilization (IVF) are two of the techniques that make up ART and help achieve successful pregnancies. This innovative technology serves as a beacon of hope for individuals grappling with infertility stemming from medical conditions, age-related factors, or genetic issues. Furthermore, ART has had a positive impact on same-sex couples and single individuals seeking to build families. Despite the ongoing ethical and moral discussions surrounding ART, its significance lies in presenting alternative routes to parenthood and overcoming reproductive hurdles for those eager to commence or expand their families.

Assisted reproductive technology (ART) Market Segmental Analysis:

Insights On Procedure

Frozen Donor

The global market for assisted reproductive technology (ART) is anticipated to be dominated by frozen donors. This part involves using frozen embryos or eggs from individuals who previously donated them. Frozen donor procedures offer several advantages, such as easier scheduling, lower costs, and increased convenience for both donors and recipients. These factors contribute to the growing popularity of frozen donor procedures, making it the dominating part in the ART market.

Fresh Donor

Fresh Donor procedures involve using fresh embryos or eggs from individuals who donate them. While fresh donor procedures are still commonly used, they may face challenges due to the requirement for synchronization between the donor and recipient's menstrual cycles. Additionally, fresh donor procedures can be more costly and involve more logistical considerations compared to frozen donor procedures. Thus, although fresh donor procedures remain relevant, they are not expected to dominate the ART market.

Fresh Nondonor

Fresh Nondonor procedures refer to cases where fresh embryos or eggs from the intended parents are used. This part is typically chosen when both partners are able to contribute gametes for the ART procedure. Although fresh nondonor procedures remain an option for couples, they are not expected to dominate the ART market due to the increasing preference for donor procedures.

Frozen Nondonor

Frozen Nondonor procedures involve using frozen embryos or eggs from the intended parents. This part offers advantages similar to frozen donor procedures, such as enhanced scheduling flexibility and reduced costs. However, unless there are specific medical reasons necessitating this type of procedure, frozen nondonor procedures are less likely to dominate the ART market compared to frozen donor procedures.

Embryo/Egg Banking

Embryo/Egg Banking involves the freezing and storage of surplus embryos or eggs for future use. This part plays a crucial role in the ART market as it enables individuals to preserve their fertility potential. However, embryo/egg banking is not expected to dominate the market itself since it is an enabling service rather than a primary ART procedure. It supports other parts, such as frozen donor procedures, by providing a reliable supply of frozen embryos or eggs.

Insights On End-use

Fertility Clinics

It is anticipated that fertility clinics would control the majority of the worldwide market for assisted reproductive technology (ART). In vitro fertilization (IVF), intrauterine insemination (IUI), and other assisted reproductive methods are offered by fertility clinics, which specialize in offering complete fertility treatments. Because they provide a variety of services and treatments to infertile people and couples, these clinics are important players in the ART business. With advancements in technology, increased awareness about fertility treatments, and growing demand for alternative options to conceive, fertility clinics have witnessed significant growth in recent years. The expertise and specialized infrastructure provided by fertility clinics make them the leading part in the global ART market.

Hospitals

While fertility clinics dominate the ART market, hospitals also play a crucial role in providing assisted reproductive technology services. Hospitals have established reproductive health departments that offer various fertility treatments and services to patients. However, their dominance in the ART market is limited compared to fertility clinics. Hospitals usually cater to a wider range of medical services and treatments, and fertility treatment might not be their primary focus. Consequently, hospitals may not have the same level of expertise and specialization as fertility clinics, leading to a lesser market share in the global ART market.

Others

The Others category refers to end-users apart from hospitals and fertility clinics. This includes specialized reproductive health centers, private practices, and standalone clinics that offer ART services. While this part holds importance in the ART market, it is expected to have a relatively smaller market share compared to fertility clinics. The lack of specialized infrastructure and expertise may limit the growth potential of these end-users in the market. However, depending on regional market dynamics and healthcare accessibility, these "Others" end-users may serve as an alternative choice for individuals seeking ART services in certain areas.

Insights On Technology

In-vitro Fertilization (IVF)

In-vitro Fertilization (IVF) is expected to dominate the Global Assisted reproductive technology (ART) market. IVF is a popular assisted reproductive technique that entails fertilizing an egg in a lab environment using sperm outside of the body. It is the recommended option for couples dealing with infertility problems since it has greater success rates than alternative techniques. The advancements in IVF techniques, such as the use of preimplantation genetic testing and cryopreservation, have further increased its popularity. Additionally, the rising incidence of infertility cases worldwide, increasing awareness about available options, and advancements in technology contribute to the dominance of IVF in the ART market.

Artificial Insemination - Intrauterine Insemination (AI-IUI)

Artificial Insemination - Intrauterine Insemination (AI-IUI) is another important player within the ART market. AI-IUI involves placing sperm directly into a woman's uterus to facilitate fertilization. This method is particularly effective for couples with mild fertility issues and is less invasive and more cost-effective compared to IVF. Although AI-IUI continues to be a popular choice for some patients, its usage and success rates are relatively lower when compared to IVF. Therefore, while AI-IUI is a significant part, it is not expected to dominate the ART market like IVF.

Frozen Embryo Replacement (FER)

Frozen Embryo Replacement (FER) is another player in the ART market. FER involves the storage and subsequent transfer of frozen embryos created during IVF cycles. This technique helps couples to have multiple attempts at pregnancy using the same embryos, increasing their chances of success and reducing the need for additional IVF cycles. FER has gained prominence due to its convenience, improved success rates, and reduced costs compared to fresh embryo transfers. However, FER is not expected to dominate the ART market as it is closely linked to the IVF procedure.

Surrogacy

Surrogacy is another sector within the ART market that involves using a third-party woman (the surrogate) to carry and deliver a child for another couple or individual. Surrogacy is a complex and highly regulated process that offers an alternative for individuals or couples who are unable to carry a pregnancy themselves. While surrogacy is an important option available within the ART market, it is not expected to dominate the industry as it is a specialized and relatively less commonly utilized method.

Ovulation Induction

Ovulation Induction is a sector of the ART market that involves the use of medications to stimulate the release of eggs in women who are experiencing ovulation issues. This method aims to increase the chances of natural conception, especially in women with ovulatory disorders. While ovulation induction is an essential part of the ART market, it is not expected to dominate the industry as it is a less invasive and lower-cost option compared to IVF.

Others

Among the various parts within the Technology category of the ART market, In-vitro Fertilization (IVF) is expected to dominate due to its high success rates, advancements in techniques, and increasing global awareness. The others category of Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Surrogacy, and Ovulation Induction, though important, are not expected to have the same level of dominance as IVF.

Insights On Product Type

Women Younger Than Age 35

The global market for assisted reproductive technology (ART) is anticipated to be dominated by the group of women under 35. This is mostly because more and more women are opting to put off having children in favor of pursuing their education or jobs. This younger age group is hence becoming more and more in need of ART operations. Additionally, advancements in technology and medical procedures have made ART more accessible and successful, further contributing to the dominance of this part. The potential for higher success rates and a longer reproductive lifespan also attract more women younger than age 35 towards ART, solidifying its position as the dominating part.

Women Older Than Age 35

While the category Women Older Than Age 35 holds importance in the Global Assisted Reproductive Technology (ART) Market, it is not expected to dominate like the part of Women Younger Than Age 35. As women age, their fertility declines, and the chances of successful conception through ART decrease. However, this part still represents a significant portion of the market due to factors such as delayed motherhood, changing social trends, and increasing awareness about ART options. Despite the challenges associated with age-related fertility decline, the advancements in ART techniques and reproductive medicine continue to offer opportunities for women older than age 35 to achieve successful pregnancies.

Global Assisted Reproductive Technology (ART) Market Regional Insights:

Europe

Europe is expected to dominate the global Assisted Reproductive Technology (ART) market. This region has a well-developed healthcare infrastructure, advanced technological advancements, strong government support, and high awareness about infertility treatments. Additionally, increasing fertility tourism in countries like Spain and Czech Republic contribute to the growth of the ART market in Europe. The presence of major market players and the high adoption of advanced ART procedures further boost Europe's dominance in this market.

North America

The North American region shows significant growth potential in the global ART market. Factors such as high disposable income, increasing awareness about infertility treatments, favorable reimbursement policies, and advancements in technology contribute to the market growth in this region. Moreover, the presence of major market players and ongoing research and development activities propel the adoption of ART procedures in North America.

Asia Pacific

Asia Pacific is a rapidly growing region in the global ART market. Factors like increasing disposable income, rising infertility rates, expanding medical tourism industry, and developing healthcare infrastructure contribute to market growth in Asia Pacific. Additionally, favorable government initiatives, growing awareness, and advancements in ART techniques drive the adoption of these procedures in countries like India, China, and Japan.

Latin America

Latin America is also witnessing significant growth in the global ART market. The region has a large population base, increasing fertility rates, and rising awareness about infertility treatments. Moreover, government initiatives, technological advancements, and growing medical tourism in countries like Brazil and Mexico contribute to the growth of the ART market in Latin America.

Middle East & Africa

The Middle East & Africa region is expected to experience moderate growth in the global ART market. Limited access to healthcare facilities, low awareness about fertility treatments, and cultural and religious barriers are some of the factors hindering the growth of the ART market in this region. However, improving healthcare infrastructure, rising awareness, and favorable government initiatives may contribute to the growth of the ART market in the Middle East & Africa in the future.

Global Assisted Reproductive Technology (ART) Market Competitive Landscape:

Prominent figures within the international Assisted Reproductive Technology (ART) sphere are pivotal in the innovation and production of sophisticated medical tools and innovations tailored for addressing fertility challenges. Additionally, they are instrumental in driving investigative efforts and delivering inclusive infertility remedies and support to a global clientele.

Prominent companies in the Assisted Reproductive Technology (ART) industry encompass California Cryobank, Thermo Fisher Scientific Inc., Merck KGaA, CooperSurgical Inc., Vitrolife AB, Ferring Pharmaceuticals, Irvine Scientific, Genea Limited, Cook Medical, and Esco Group. These companies are actively engaged in the innovation, manufacture, and dissemination of diverse ART offerings. They cater to the escalating need for fertility interventions, encompassing in-vitro fertilization (IVF), gamete and embryo preservation, gestational surrogacy, and other allied reproductive methodologies. Through their wide-ranging product arrays and expansive global footprints, these pivotal stakeholders significantly contribute to propelling the advancement of the ART sector.

Global Assisted Reproductive Technology (ART) Market COVID-19 Impact and Market Status:

The Global Assisted Reproductive Technology (ART) market has experienced notable effects due to the Covid-19 pandemic, causing disturbances in clinic functionalities and postponements in fertility procedures.

The Assisted Reproductive Technology (ART) market has faced notable effects from the COVID-19 pandemic. Lockdowns and limitations on non-essential medical procedures have led to a reduction in the demand for ART treatments during the initial phases of the crisis. A number of fertility clinics had to temporarily halt their services, resulting in a decrease in the volume of procedures performed. Furthermore, the economic instability spurred by the pandemic has impacted the financial capacity of individuals and couples to pursue ART treatments, thereby hindering market expansion. However, with the stabilization of the situation and the easing of restrictions, it is anticipated that the market will gradually recover.

Heightened awareness concerning the significance of family planning and fertility treatments might also play a role in the market's resurgence. Nevertheless, it remains crucial to recognize the uncertainties surrounding the long-term impact of the pandemic on the ART market, with variables such as vaccine distribution, economic recuperation, and shifts in healthcare policies holding key sway over its future trajectory.

Latest Trends and Innovation of the Assisted Reproductive Technology (ART) Market:

• On September 3, 2020, CooperSurgical Inc. acquired Resolution Analytics, a pioneer in the development of artificial intelligence products for use in IVF laboratories.
• On March 23, 2021, Thermo Fisher Scientific Inc. announced the acquisition of Mesa Biotech Inc., a company specializing in the development of point-of-care molecular diagnostic tests, including tests for reproductive health.
• On January 18, 2022, Vitrolife AB acquired IGENOMIX, a global leader in reproductive genetics and molecular diagnosis.
• On November 10, 2021, Merck KGaA launched the Gavi®ART, a non-invasive embryo selection system based on artificial intelligence and machine learning algorithms.
• On July 7, 2020, Fujifilm Corporation announced the development of a 3D printing system for fabricating human skin, which could have potential applications within the field of assisted reproductive technology.
• On December 9, 2021, IVF Bioscience Ltd. introduced Vitrolife EmbryoFreeze, a new embryo vitrification kit designed to improve cryopreservation techniques in ART.

Assisted Reproductive Technology (ART) Market Growth Factors:

The expansion of the Assisted Reproductive Technology (ART) industry is propelled by various factors including rising rates of infertility, advancements in healthcare technology, and heightened awareness regarding ART techniques.

The market for assisted reproductive technology (ART) has experienced notable growth in recent times, driven by several key factors. Firstly, there has been a rise in global infertility rates, with the World Health Organization reporting that around 15% of couples worldwide are affected by this issue. This has led to an increased demand for ART procedures as a solution.

Secondly, advancements in technology and techniques have enhanced the success rates of ART interventions, making them more appealing to couples seeking fertility treatments. Innovations such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) have significantly contributed to the expansion of the ART market. Changing societal norms and lifestyle patterns, such as delayed pregnancies and a heightened awareness of fertility treatment options, have also played a role in driving market growth.

Furthermore, improved healthcare infrastructure, higher healthcare spending, and favorable government regulations in various nations have further propelled the market's development. The increasing acceptance and accessibility of third-party reproduction choices like egg and sperm donation, surrogacy, and gestational carriers have added to the positive impact on the ART market. Collectively, these factors are driving the growth of the ART market, providing optimism and choices for couples grappling with infertility challenges.

Assisted reproductive technology (ART) Market Restraining Factors:

The restricted availability and hefty expenses associated with Assisted Reproductive Technology (ART) services present notable obstacles to the expansion of the market.

The market for Assisted Reproductive Technology (ART) has seen notable growth in recent years, yet it is not without its challenges. A primary obstacle faced by the ART industry is the substantial costs associated with these procedures. Expenses related to fertility treatments, including in vitro fertilization (IVF) and other ART methods, are often significant and not typically covered by insurance, thereby creating a financial barrier for many couples seeking fertility assistance.

Moreover, ethical issues surrounding ART, particularly concerning practices like embryo freezing and selective reduction, have triggered debates and regulatory discrepancies among different nations, further impeding the widespread acceptance and utilization of ART. Additionally, the success rates of ART can vary based on factors such as age and underlying health conditions, which may limit the efficacy of these treatments for certain individuals. Furthermore, the lack of awareness and information about ART can pose challenges, as individuals may not have access to the necessary resources to make informed decisions regarding these procedures.

Nevertheless, despite these obstacles, the ART market is advancing with ongoing research and technological developments offering hope for individuals grappling with fertility issues. Efforts to decrease costs, enhance success rates, and address ethical concerns are underway, holding promise for those seeking assisted reproductive options.

Key Segments of the Assisted Reproductive Technology (ART) Market

Procedure Overview

• Fresh Donor

• Fresh Nondonor

• Frozen Donor

• Frozen Nondonor

• Embryo/Egg Banking

End-Use Overview

• Hospitals

• Fertility Clinics

• Others

Technology Overview

• In-vitro Fertilization (IVF)

• Artificial Insemination - Intrauterine Insemination (AI-IUI)

• Frozen Embryo Replacement (FER)

• Surrogacy

• Ovulation Induction

• Others

Product Type Overview

• Women Younger Than Age 35

• Women Older Than Age 35

Regional Overview

North America

• US

• Canada

• Mexico

Europe

• Germany

• France

• U.K

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Rest of Asia Pacific

Middle East and Africa

• Saudi Arabia

• UAE

• Rest of Middle East and Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America